Immunis to use MRI-based AI muscle analysis for sarcopenia trial
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…
The US Food and Drug Administration (FDA) has granted approval to DiscGenics for a Phase III clinical trial of its…
Swing Therapeutics has published positive results from the Phase III trial of its digital therapeutic, Stanza, for the treatment of…
Alvotech has reported positive topline data from a confirmatory patient study, AVT03-GL-C01, assessing AVT03 as a proposed biosimilar to denosumab…
The University of Kansas (KU) Medical Center in the US has released preliminary data from the Phase I/II trial of…
Dianthus Therapeutics has received authorisation from the US Food and Drug Administration (FDA) to begin a new trial with its…
Pfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene therapy, fordadistrogene movaparvovec,…
Gain Therapeutics’ GT-02287 was found to be safe and tolerable in the Phase I trial of the therapy in healthy…
US-based biotechnology company Edgewise Therapeutics has reported positive two-year topline data from the ARCH clinical trial of sevasemten (EDG-5506) in…
Atamyo Therapeutics has received regulatory clearance in Europe to initiate a Phase Ib clinical trial for its gene therapy, ATA-200,…